Last checked at 7 Nov 2019 12:03
LONDON MARKET MIDDAY: US-China Hopes Boost Market; BOE Holds UK Rates
LONDON MARKET MIDDAY: US-China Hopes Boost Market; BOE Holds UK Rates
Read more
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Hikma Pharmaceuticals Share News (HIK)
HIK Share
Price
HIK Share
News
HIK Share
Chat
HIK Share
Trades690
HIK
Live RNS
HIK Share
Charts
HIK Level 2
Console
HIK Live
Share Price
HIK Broker
Ratings
HIK Directors
Deals
HIK Financial
Diary
HIK
Fundamentals
HIK Short
Positions
HIK
Media
Hikma Pharmaceuticals Information
Share Price Information for Hikma Pharmaceuticals (HIK)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
1,820.00
Bid:
1,820.00
Ask:
1,822.00
Change:
2.00 (0.11%)
Spread:
2.00 (0.11%)
Open:
1,825.00
High:
1,832.00
Low:
1,813.00
Prev. Close:
1,818.00
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.7 Nov 2019 08:57
Hikma Pharmaceuticals Keeps 2019 Guidance As All Units Deliver Growth
Hikma Pharmaceuticals Keeps 2019 Guidance As All Units Deliver Growth
Read more7 Nov 2019 07:49
Hikma Pharmaceuticals maintains guidance as it invests in growth
(Sharecast News) - Hikma Pharmaceuticals updated the market on its current trading on Thursday, reporting that its global injectables business was continuing to perform well.
Read more31 Oct 2019 15:46
UK Earnings, Trading Statements Calendar - Next 7 Days
UK Earnings, Trading Statements Calendar - Next 7 Days
Read more7 Oct 2019 15:00
UPDATE 1-U.S. Supreme Court rejects Acorda appeal in MS drug patent fight
(Adds background to case, paragraphs 3-9)By Andrew ChungWASHINGTON, Oct 7 (Reuters) - The U.S. Supreme Court on Monday declined to hear Acorda Therapeutics Inc's appeal of a lower court ruling that allowed generic versions of its multiple sclerosi...
Read more7 Oct 2019 14:32
U.S. Supreme Court rejects Acorda appeal in MS drug patent fight
WASHINGTON, Oct 7 (Reuters) - The U.S. Supreme Court on Monday declined to hear Acorda Therapeutics Inc's appeal of a lower court ruling that allowed generic versions of its multiple sclerosis treatment Ampyra and caused the drug's sales to plumm...
Read more17 Sep 2019 15:02
FTSE 250 movers: Sirius plummets, Sophos climbs
(Sharecast News) - London's FTSE 250 was down 0.3% at 20,003.51 in afternoon trade on Tuesday, as Sirius Minerals led the index lower.
Read more11 Sep 2019 07:00
RPT-GRAPHIC-FTSE 100's changing face: A trip down memory lane
(Repeats Tuesday story without changes)By Thyagaraju AdinarayanLONDON, Sept 10 (Reuters) - Marks & Spencer's exit from the FTSE 100 underlines how times have changed since the blue-chip index was launched in 1984, when it was dominated by British ...
Read more10 Sep 2019 14:02
GRAPHIC-FTSE 100's changing face: A trip down memory lane
By Thyagaraju AdinarayanLONDON, Sept 10 (Reuters) - Marks & Spencer's exit from the FTSE 100 underlines how times have changed since the blue-chip index was launched in 1984, when it was dominated by British companies including household names lik...
Read more4 Sep 2019 17:52
TOP NEWS: Marks & Spencer's 35 Year Spell In FTSE 100 Comes To An End
LONDON (Alliance News) - FTSE Russell confirmed on Wednesday that the following changes will take effect to its UK indices from the market open on Monday, September 23, after completing its 100 of
Read more4 Sep 2019 09:32
BROKER RATINGS SUMMARY: Deutsche Bank Raises BHP And Cuts Antofagasta
(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:----------FTSE 100----------DEUTSCHE BANK RAISES BHP
Read more23 Aug 2019 10:07
M&S faces FTSE 100 demotion for the first time
(Sharecast News) - Marks & Spencer is likely to drop out of the index of leading shares for the first time since the FTSE 100 was formed 35 years ago as the retailer suffers the effects of high street decline and its own problems.
Read more13 Aug 2019 12:30
DIRECTOR DEALINGS: Hikma Pharma Finance And M&A Chiefs Sell Shares
(Alliance News) - Hikma Pharmaceuticals PLC said Tuesday its finance chief and mergers & acquisition head sold shares in the FTSE 250-listed drugmaker worth GBP2.5 million in separate on sold
Read more9 Aug 2019 16:58
LONDON MARKET CLOSE: Mixed End Amid Weak UK Data, Trade Tension Angst
(Alliance News) - Stock prices in London closed generally lower on Friday following the release of weaker-than-forecast economic growth figures and renewed focus on tensions between the US and The
Read more9 Aug 2019 12:23
LONDON MARKET MIDDAY: Mixed Indexes As Weak Data Crimps Upbeat WPP
(Alliance News) - Stock prices in London were mixed midday Friday following weaker-than-forecast economic growth figures, despite WPP leading a number of blue chip and mid caps on
Read more